ISSN:

Journal Home

Translational Oncology Q1 Unclaimed

Neoplasia Press, Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Translational Oncology is a journal indexed in SJR in Oncology and Cancer Research with an H index of 72. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2070 €. The scope of the journal is focused on translational oncology, cancer, genetics, endocrinology, tumour. It has an SJR impact factor of 1,263 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,263.

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Oncology (Q1) Cancer Research (Q2)

Price

2070 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,263

SJR Impact factor

72

H Index

231

Total Docs (Last Year)

831

Total Docs (3 years)

11856

Total Refs

3891

Total Cites (3 years)

812

Citable Docs (3 years)

4.53

Cites/Doc (2 years)

51.32

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Molecular Cancer Q1
Journal of Thoracic Oncology Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of Hematology and Oncology Q1

Compare this journals

Aims and Scope

Translational oncology Cancer Genetics Endocrinology Tumour